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The biologic activities of retinoic acid and 3,4-didehydrore-
tinoic acid, two endogenous vitamin A derivatives in various 
tissues, were compared to their affinities for the nuclear reti-
noic ac.id receptors ~nd. their ability. to indu.ce transcript~onal 
activatlOn. Both retlnolds were eqUIpotent Inducers of differ-
entiation of F9 teratocarcinoma cells. In a morphologic assay, 
using reconstructed skin, retinoic acid and 3,4-didehydrore-
tinoic acid inhibited keratinization at a concentration of 
100 nM. In cultured keratinocytes, a 50% inhibition of the 
production of the keratinocyte trans glutaminase enzyme was 
achieved with about 20 nM for both retinoids. The in vitro 
binding to the nuclear retinoic acid receptors a, p, and y 
showed that retinoic acid and 3,4-didehydroretinoic acid had 
almost equal affinities for the receptors with Kds ranging 
from 3 to 47 nM. The transcriptional activation resulting 
Since the discovery of nuclear retinoic acid receptors (RARs). retinoids (vitamin A derivates) can be regarded as hormones that mediate their differentiation and morpho-genetic effects by modulating the transcription of ensem-bles of developmentally regulated genes. In the chick em-
bryo, two endogenous retinoids with morphogenetic properties 
have been identified so far: retinoic acid (RA) and 3.4-didehydrore-
tinoic acid (ddRA) [1.2] . Because the local concentration of ddRA in 
the embryo is about six times higher than the concentration of RA 
[2]. the former compound might be even more important than RA 
during embryogenesis. However, it should be stressed that the 
mechanism of action of retinoids in the chick limb bud is not com-
pletely elucidated. For example, it has been suggested that retinoids 
act indirectly by inducing. perhaps at the transcriptional level [3.4], 
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from the addition of the two retinoids to cells co-transfected 
with a, p, or y retinoic acid receptor expression vectors and a 
retinoic acid responsive element linked to the chlorampheni-
col acetyltransferase reporter gene was similar. Finally, it was 
demonstrated that retinoic acid did not metabolize to 3,4-di-
dehydroretinoic acid, and a slow conversion of 3,4-didehy-
droretinoic acid into retinoic acid was not sufficient to ex-
plain the biologic effects produced by the former compound. 
In conclusion, the present study demonstrates that retinoic 
acid and 3,4-didehydroretinoic acid have the same activity in 
several different test systems, but their metabolism differs 
depending on the cell type used. Key words: ep idermis/retinoic 
acid receptors/retinoids/v itMnil1 A. ] Invest Dermato/1 02:49 - 54, 
1994 
cells in the zone of polarizing activity to produce actual morpho-
gens. 
In epidermis, rerinoids are known to play an important role in the 
proliferation and differentiation of keratinocytes. So far the interest 
has been concentrated solely on retinoic acid and recently the meta-
bolic conversion of retinol (ROH) into RA in cytosolic extracts 
from differentiating keratinocytes was established [5]. However, in 
human epidermis a considerable amount of ROH is converted into 
3.4-didehydroretinol (ddROH) [6.7], the putative precursor of the 
morphogenetic substance ddRA [2] . The epidermal concentration 
of ddROH is increased in several skin diseases, especially in connec-
tion with hyperproliferation [7] . Considering the conversion of 
ROH to ddROH in keratinocytes and the existence of specific re-
tinol-dehydrogenases. it is possible that. as in rhe embryo, both RA 
and ddRA are generated locally in adult human epidermis. In the 
present work, using several in lIitro models of morphogenesis and 
differentiation, we compare the biologic properties ofRA and ddRA 
to their affinities for the RAR ex. P, and y receptors. Furthermore, 
the transcriptional activation of a reporter gene linked to a retinoic 
acid responsive element by RA and ddRA in combination with 
RARs is analyzed using co-transfection experiments. 
MATERIALS AND METHODS 
Chemicals RA. ddRA. and Ro 12-0586 were gifts from Holfmann-
LaRoche (Basel. Switzerland). The purity ofRA and ddRA was determined 
by HPLC to be > 99% and > 97%. respectively. CD367 and [3HjCD367 
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Figure 1. Formulas of the natural and synthetic retinoids used. 
were synthesized in CIRD Galderma. Figure 1 shows the structural formul as 
of the retinoids discussed in the tex t. 
Reconstructed Skin The preparation of dermal equivalents (collagen 
lattices contracted by human fibroblasts) and the method for seeding and 
culturing epidermal cells on these substrates were described in detail previ-
ously [8]. Briefl y, adult interfollicular epidermal cells isolated from human 
breast skin and amplified in primary culture were used. The cultures (dermal 
equivalents seeded with keratinocytes) were first kept submerged for 1 week 
to form a confluent monolayer and then rai sed on a stainless steel grid at the 
air- liquid interface to produce a stratified and keratinized epithelium during 
another week. The tissue culture medium consisted of minimal essential 
medium (MEM) supplemented with 10% fetal calf serum, epidermal growth 
facto r (1 0 ng/ml), hydrocortisone (0.4 flg/ml) , and cholera toxin (10- 9 M). 
Retinoids , in dimethylsulfoxide, were added to the culture medium when 
the cultures were at the air-liquid interphase. Medium was changed three 
times weekly. Histology was performed by staining vertical paraffin sections 
with haemalum-phloxin-saffron. 
Differentiation ofKeratinocytes in Serum-Free Medium and Kerati-
nocyte Transglutaminase Assay The method for determination of reti-
noid activi ty by the enzyme-linked immunosorbent assay has been described 
in detail previously [9]. Briefly, keratinocytes were cultured in serum-free 
MC DB153 tissue culture medium (ICBM, C lonetics, San Diego, CAl in 
96-well clusters for 4 d in the presence of different retinoid concentrations, 
CD367, a very potent stable synthetic retinoid being used as a control. The 
amount of the membrane-bound keratinocyte transglutaminase (TGm) was 
then quantified, without any extraction or purification step, using a T Gm-
specific monoclonal antibody (B.Cl) and a peroxidase-conjugated second 
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antibody [9]. The dose-response curves obtained with the enzyme-linked 
immunosorbent assay technique were evaluated with the MlNSQ curve-fi t-
ting program (MicroMathScientific Software, Salt Lake C ity, UT) running 
on an IBM Personal computer. The data were fi tted by nonlinear regression 
[9]. For calculations of the retinoid concentration leading to a 50% inhibi-
tion of TGm (ICso ), the residual activity at 10- 6 M was subtracted. 
Assay of Biologic Activity on F9 Cells The activating effect of reti-
noids on the plasminogen activator, a marker of differentia tion of F9 murine 
embryonal carcinoma cells, was assayed after 3 d in culture as prev iously 
described [1 0]. The retinoid concentration inducing 50% plas minogen acti-
vator production (ACso ) relative to the maximum of the pre- response curve 
was calculated as before [11] . 
Determination of Retinoid Affinities for lX, p, and y RARs A full 
description of th e method has already been published [1 2]. Briefl y, nuclear 
extracts were prepared from cos7 cel ls transfected with express ion vectors 
for human a, /1, and y RARs (y expression vector was purchased fro m La Jolla 
Cancer Research Foundation, La Jolla, C Al . These extracts were incubated 
for 2 h with [3H] CD367 (a high-affini ty retinoid) and varying concentra-
tions of unlabeled C D367 or the natural retinoids (i .e. , RA and ddRA) used 
in this study [10,13]. The amoun t of radiolabel specifica lly bound to RARs 
was separated from free ligand by high-perfo rmance size exclusion chroma-
tography. Competition binding curves were analyzed by the MINSQ-pro-
gram and Kds were calculated. 
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Figure 2. Morphology of the epithel ium fo rmed by human keratinocytes 
grown for 2 weeks on a collagen lattice emerged the second week in the 
presence of added RA (A, C, E, G, I, K), or ddRA (B, D, F, H, j , L) (see 
Materials alJd Methods for details). The concentration of either RA or ddRA 
was as follows: 0 M (A, B) , to- 10 M (C, D) , 10- 9 M (E, F), 10- 8 M (G, H), 
10- 7 M (I, j) , 10- 6 M (K, L) . (Bar, 30 flm.) 
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Table I. Retinoic Acid (RA) and 3,4-Didehydroretinoic acid (ddRA): A Comparison of Their Biologic Activities on Morphogenesis 
and Differentiation of Epidermis and F9 Cells and of Their Affinities for a, p, and yRARs' 
Reconstructed 
Epidermis' 
Parakeratosis (nM) 
RA tOOJ 
ddRA tOo 
CD367 
• CD367 is used as a reference (see Materials and Methods) . 
• Data presented in Figure 2. 
, Data presented in Figure 3. 
'Values represent mean of two experiments. 
, Values represcnt mean ± SO of three experiments. 
'Values represent mean ± range of two experiments. 
Biologic Activity 
Trallsglutaminase' 
ICso (nM) 
21.3 ± 7.5' 
20.5 ± 2.sr 
0.1 
Transfection Experiments The following expression vectors were 
used: human RARs (Q, fl, and y) and RARE-tk-CAT, a retinoic acid -
responsive element derived from the RARjJ gene cloned into the 
pBLCAT8+ plasmid. Additionally, the jJ-galactosidase expression vector 
pCHII0 (Pharmacia LKB Biotechnology, Bromma, Sweden) and pBS 
(Strata gene, La Jolla, CAl were used for normalization of transfection effi-
ciency and as carrier DNA, respectively. CV-I cells obtained from Flow Lab 
(Ayershirc, Scotland) were cultured in Dulbecco's MEM (DMEM) (Flow 
Lab) containing 10% fetal bovine serum in 60-mm plates in an atmosphere 
of 5% CO2 in air. The cells (2 X 10'jcm2 ) were co-transfected with 3.4lJ.g 
of pCH110 and 4IJ.g of pBS. RAR (1.6IJ.g) was introduced into the cells 
together with Illg of RARE-tk-CAT using CaPO, co-precipitation as de-
scribed (14]. 
After transfection, cells were maintained in medium containing charcoal-
stripped serum. Retinoids were added in concentrations ranging from 
0.1 nM to 10 IJ.M . CAT-activity was determined after 24 hs by liquid scin-
tillation counting [14] after normalization for jJ-galactosidase activity (15]' 
The retinoid concentration required to obtain half-maximal stimulation 
(EDso value) was calculated by non-linear regression using the MINSQ 
program. 
Retinoid Analysis The concentrations of RA and ddRA in cultured cells 
and medium were determined by reversed-phase high-performance liquid 
chromatography using a non-hydrolytic extraction procedure. Briefly, in-
ternal standard (Ro 12-0586), ethanol (500 1J.1) , phosphate-buffer, pH 4.5 
(600 Ill), and butylated hydroxytoluen, was added to a test tube containing 
cells or medium (250 IJ.I). The samples containing cells were subjected to a 
20-second burst using a Polytron homogenizer. After extraction twice with 
hexane rhe pooled hexane phases were evaporated and redissolved in metha-
nol and subjected to analysis by reversed-phase high-performance liquid 
chromatography as described (16]. The amount of RA or ddRA was related 
to the volume of cells or medium and expressed aSIJ.M. The cell volume was 
calculated from the protein content of the samples and the known protein-
cell volume ratio (1 mg of cellular protein = 251J.1 of cells). The protein 
content was measured by a biuret technique using bovine serum albumin as 
protein srandard. 
RESULTS 
Inhibition of Keratinization in the Reconstructed Epidermis 
We used the reconstructed epidermis model as a morphologic assay 
of the potency of retinoids to inhibit terminal differentiation. His-
tology of the sections allows us to determine the retinoid concentra-
tion that produces a complete inhibition of formation of granular 
and cornified layers (parakeratosis). 
The results (Fig 2) show that a concentration of 100 nM ofRA or 
ddRA is sufficient to inhibit the formation of these layers, whereas 
only 1 nM of CD367 (see Table I) is sufficient to produce a similar 
effect. 
Plasminogen 
Activator (F9 cells) Affinity for RARs 
ACso (11M) Type Kd (nM) 
200J Q 13 
fl 3 
Y 3 
180 Q 47 
fl 5 
Y 19 
0.6 Q 5 
fl 3 
Y 1.5 
Inhibition of Keratinocyte Transglutaminase Production in 
Keratinocytes Cultured in Serum-Free Medium Because ke-
ratinocyte transglutaminase is a key enzyme of epidermal differen-
tiation expressed in granular layers and involved in the formation of 
cornified layers, this marker is particularly suitable to quantify the 
effects of retinoids in inhibiting keratinization. In the dose-response 
curves obtained after plotting the amount of transglutaminase mea-
sured versus retinoid concentration, the concentration correspond-
ing to 50% inhibition of the accumulation of the transglutaminase 
enzyme (ICso ) is determined. The results (Fig 3) show that transglu-
taminase production is inhibited with an lCso of approximately 
20 11M of RA and ddRA. For comparison, the value obtained for 
CD367 in this assay was approximately 0.1 11M (see Table I). 
Retinoid Activity in F9 Cells As shown in Table I, the ACso are 
very similar for RA and ddRA: 200 nM and 180 11M, respectively, 
whereas only 0.6 nM is necessary in the case of CD367. 
Retinoid Affinities for a, p, and y RARs In Vitro Retinoid 
binding ill lIitro to the RARs [13] obtained from nuclear extracts of 
cells transfected with a, p, and y RAR expression vectors shows that 
RA and ddRA bind to RARa and P with almost equal affinities, 
whereas RA showed higher affinity than ddRA for RARy (Table I). 
The values obtained for CD367 used as a reference showed, by 
comparison with RA, an affinity of the same order [13]. 
Transcriptional Activation in CV-1 Cells The CAT activities 
in CV-l cells transfected with RARE-tk-CAT plus RARs (a, p, 
or y) and exposed to different concentrations of RA and ddRA are 
shown in Fig 4. As can be seen, the retinoid concentrations corre-
sponding to 50% of maximum CAT activity (EDso) were 100, 100, 
and 20 11M, respectively, for the three receptors (a, p, and y). There 
was no obvious difference between RA and ddRA. 
Retinoid Concentrations in Cells and Media To examine a 
possible degradation and metabolic intercOllversion of RA and 
ddRA during incubation, cells and media from the aforementioned 
experiments were analyzed by high-performance liquid chroma-
tography. Table II shows the retinoid concentrations 24 h after 
addition of 1 J.1M of RA or ddRA. There were some notable differ-
ences between the cell lines and between the two retinoids. Kerati-
nocytes exposed to RA contained similar amounts of retinoid when 
cultured submerged or at the air-liquid interface, but the fonner 
cells appeared to consume RA more rapidly. F9 cells contained only 
minute amounts of RA and no retinoid remained in the m.edium, 
probably reflecting an extensive degradation of RA. Intermediate 
concentrations of RA were found in CV-l cells and medium ex-
posed to RA. None of the cell lines converted significant amountS of 
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Figure 3. Dose-response curves showing the inhibition by RA and ddRA of 
the production of membrane-bound transglutaminase (TGm) in cultured 
human keratinocytes using an enzyme-linked immunosorbent assay (see 
Materials alld M. etllOds). The data shown was obtained in representative exper-
Iments and represents mean ± SD (n = 6). (A), RA; (B), ddRA. 
RA to ddRA. Divergent results were obtained after addition of 
ddRA. Only in the case of CV-l ce lls were significant amounts of 
ddRA present in the medium after 24 h, and the cellnlar retinoid 
concentration was less than one quarter that observed after addition 
of RA. Small high-performance liquid chromatography peaks 
corresponding to RA were detected in all ddRA-containing sam-
ples. The RA concentration was about 10% of the ddRA value in 
CV -1 cells and 20% of the ddRA value in F9 cells. Relatively higher 
values were seen in keratinocytes, but these values correspond to 
only 0.5 - 2% those obtained after addition ofRA. On the whole, 
the investigated cell lines (with the possible exception of F9) 
seemed to degrade ddRA at a higher rate than RA and were probably 
able to convert some ddRA to RA. However, the extent of ddRA to 
RA conversion cannot be evaluated because our authentic ddRA 
batch, despite re-chromatography, was contaminated with small 
amounts (3%) of RA, the relative contribution of which will proba-
bly increase during incubation as a result of the more rapid degrada-
tion of ddRA. 
DISCUSSION 
Retinoids have profound and sometimes paradoxical effects on pro-
liferation and differentiation of various types of cells. For example, 
they induce differentiation of F9 teratocarcinoma cells and inhibit 
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Figure 4. Dose-response curves of transcriptional activation of RARE-tk-
CAT in the presence of RA and ddRA in CV-l ce lls co-transfectcd with 
RARet (A) , RAR.8 (B), and RARy (C) . The data shown are the mean ± SD 
of four to six experiments. The data were fitted as described under Materials 
alld Methods. 
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Table II. Concentrations of Retinoic Acid (RA) and 3,4-0idehydroretinoic Acid (ddRA) in Various Cell Types and in the Medium 
(shown in parentheses) 24 h After Addition of 1 J.lM of Either Retinoid 
RA Addition ddRA Addition 
Cell Type' 
KC grown with 3T3 fibroblasts 
KC grown at the air-liquid interface 
F9 
CV-l 
RA 
18.4b (0.11) 
12.2 (3.34)J 
0.09 (NO) 
1.56 (1.27) 
ddRA 
NO' (NO) 
NO (NO) 
NO (NO) 
NO (NO) 
RA 
0.37 (NO) 
0.067 (NO) 
0.013 (NO) 
0.04 (0.1) 
ddRA 
0.34 (NO) 
0.026 (ND) 
0.066 (ND) 
0.29 (1 .25) 
• In the case of keratinocytes (KC) and F9 cells the analyzed samples were frolll the third exchange (day 3) of retinoid-containing medium . 
• The values represent means of duplicate experiments. 
' NO, not detected (detection limit in cells is 5 nM and in medium is 10 nM ofRA and ddRA). 
, For unknown reasons the RA concentration in the medium was about three times higher than at the onset of the experiment. Presumably, KC cultured at the air-liquid interface 
reJeasc RA back to the medium after an initial saturation occurring during the first and second exchanges of RA-supplcmcntcd medium. 
differentiation of epidermal keratinocytes. Our results show that 
RA and ddRA are equipotent inducers of F9 cell differentiation 
(induction of plasminogen activator) and also inhibits terminal dif-
ferentiation of epidermal keratinocytes cultured at the air-liquid 
interface (induction of parakeratosis) at similar concentrations 
(summarized in Table I). Epidermal transglutaminase, a key enzyme 
in terminal differentiation ofkeratinocytes, was inhibited to 50% by 
both RA and ddRA at concentrations (ICso ) close to the Kds for 
RARs . This suggests that the biologic activities of these compounds 
are directly related to their affinity for the receptors. One of the 
receptors, RARP, has previous ly been shown to be upregulated by 
retinoids in an autocrine loop fashion in several different types of 
cells [17 -20]. In mouse melanoma cells, the induction of RARP 
mRNA expression by RA was recently found to be a hundred-fold 
higher than by ddRA [21]. Using a synthetic CAT-reporter gene, 
regulated by the RARP-RARE, we investigated in co-transfection 
experiments whether RA and ddRA differently induce transcip-
tional activation of this gene when combined with different RARs. 
As shown in Fig 4, ddRA is as effective as RA at inducing the 
CAT-reporter gene when combined with either a, p, or y RARs. 
The weakest induction of CAT transcription was obtained with 
RARa, whereas RARP or RARy produced higher and similar in-
ductions. The transcriptional activation by RA and ddRA of other 
response elements has previously been shown to be similar [22,23]. 
One of the first observations using RARE-tk-CAT in CV -1 cells 
was that the CAT-stimulation was generally higher than with the 
(TREh-tk-CAT. Moreover, the EOso values obtained for RARE-
tk-CAT were 5 - 20 times higher than previously reported for 
(TRE3h-tk-CAT [14] . The EOso values obtained with RARE-tk-
CAT were 6-20 times higher than the binding values for RA and 
ddRA obtained with purified nuclear receptor proteins (Table I). A 
possible explanation to this is that exogenous retinoids are more 
readily metabolized during cell culture than during incubation with 
nuclear extracts. Evidence for an extensive catabolism of ddRA was 
obtained in keratinocytes and F9 cells. Thus 24 h after addition of 
1 J.lM ddRA to the medium only small amounts of retinoids were 
present in the cells (0.03 - 0.3 J.lM) and no retinoids were detectable 
in the media. The monkey kidney epithelia l CV-l cells behaved 
differently; the cellular content of ddRA was the same as for other 
cell lines but the medium contained the expected amount (about 
1 J.lM) of retinoid, suggesting that CV-1 cells have a slow metabo-
lism of ddRA. Similarly, CV-l cells consumed little, if any, of added 
RA and the cellular content ofRA after 24 h (1.6 J.lM) was interme-
diate to that of other cell types and five times the corresponding 
ddRA value. The overall results suggest that i) various cell lines 
differ tremendously in their ability to accumulate and metabolize 
exogenous RA and ddRA, ii) in a given cell line RA usually accumu-
lates to a larger extent than ddRA, and iii) re lative to RA the most 
extensive metabolism of exogenous ddRA occurred in human kera-
tinocytes, i.e., cells that express the 3,4-didehydro metabolic path-
way under normal conditions [6]. 
Another factor that might obscure the results when comparing 
the biologic activities of RA and ddRA are metabolic interconver-
sions that have been reported to occur at least in the chick wing bud 
system [2]. However, topical application of 1 J.lCi of [3H]RA to 
human skin for 24 h does not produce detectable levels of [3H]ddRA 
in epidermis (Vahlquist, unpublished observation) . Also, RA was 
not converted to ddRA by any of our cell lines and only smaJl 
amounts ofRA were detected when ddRA was added to the cultures 
(see Table II). Thus we are confident that ddRA exerts its activities 
without first being converted to RA. This does not, however, ex-
clude the existence of other biologically active metabolites of ddRA. 
To the contrary, we think this is likely the case, because in several 
models of epithelial differentiation ddRA was as active as RA but at 
cellular concentrations far below those attained with RA additions 
(see Table II). Yet both compounds activate RAREs with similar 
potency. To further elucidate this possibility one needs to know the 
cellular concentrations of RA and ddRA at different time points of 
incubation and the time delay between the peak concentratioJ1 
values and the maximal expression of biologic activity. 
In conclusion, we have shown that ddRA and RA bind to the 
RARs with similar affinities, induce transcriptional activation with 
the same dose dependency, and exert similar effects in models of 
epidermal differentiation. Thus, ddRA appears-alike RA-to 
fulfi ll the requirements of an active vitamin A metabolite. Consid-
ering the possibility that under physiologic conditions many types 
of epithelial cells of human origin produce both RA and ddRA, one 
might predict that the regulation of gene expression by vitamin A 
depends not only on the composition and amounts ofRARs but also 
on the tissue-specific production of these two ligands. Importantly, 
we show that RA is not metabolized into ddRA by the cells but a 
minor conversion of ddRA to RA cannot be ruled out. It remains to 
be determined whether these two hormonal forms of vitamin A 
behave similarly in the embryo, for instance in transgenic animals 
bearing RARE-lacZ constructs. 
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